Status:
UNKNOWN
EUS-Elastography and Contrast-Enhanced EUS Diagnostic Accuracy in the Differential Diagnosis of Subepithelial Gastrointestinal Tumors
Lead Sponsor:
Istituto Clinico Humanitas
Conditions:
Gastrointestinal Subepithelial Tumors
Eligibility:
All Genders
18-85 years
Brief Summary
The differentiation among the Gastrointestinal Subepithelial Tumors (SETs) represents a clinical challenge. Endoscopic Ultrasound (EUS) alone may be ineffective in differentiating SETs subtypes, and t...
Eligibility Criteria
Inclusion
- Patients with GI SETs scheduled for EUS-FNB
- Patients with age \> 18 but \<85 years
Exclusion
- Patients with GI SETs \<15mm
- severe coagulopathy defined as abnormal prothrombin time (PT) or partial thromboplastin time (PTT) that does not normalize after administration of fresh frozen plasma
- severe cardiopulmonary diseases and severe chronic kidney disease defined as glomerular filtration rate (GFR) \< 15 ml/min
- known allergic disposition to SonoVue®
- pregnancy
Key Trial Info
Start Date :
January 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04695262
Start Date
January 27 2021
End Date
December 31 2023
Last Update
March 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endoscopy Unit, Humanitas Research Hospital
Rozzano, Milano, Italy, 20089